Cohlhepp Ryan bought BCAX
September 8, 2026 · Form 4 insider transaction
Cohlhepp Ryan bought 17,500 shares of Bicara Therapeutics Inc. at $3.79 per share, a transaction worth $66.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,500
Price
$3.79
Total value
$66.3K
InsiderCohlhepp Ryan
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 8, 2026
Filing dateSeptember 10, 2026
Shares owned after199,141
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026.